Mirum Pharmaceuticals, Inc. MIRM Common stock issuance for private placement
Common stock issuance for private placement at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPrivatePlacement.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s common stock issuance for private placement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s common stock issuance for private placement?
- Mirum Pharmaceuticals, Inc. (MIRM) reported common stock issuance for private placement of $259.95M in Q1 2026.
- What does common stock issuance for private placement mean?
- This represents the cash inflows generated from the sale of equity securities directly to institutional or accredited investors outside of public markets. It is a critical source of capital for biopharmaceutical companies to fund research and development or commercialization efforts. It reflects the company's ability to attract private investment to support growth.